 The purpose of this study is to investigate the effectiveness of Alvesco Ciclesonide compared with usual asthma care in the primary care setting. Patients with a history of asthma for at least 6 months and who, in the opinion of the physician, meet the clinical requirements for treatment with inhaled steroids ICS will be enrolled. They will either receive Alvesco or usual care. 